Insilico Medicine Partners with SK Biopharm for AI-Driven Drug Discovery
Insilico Medicine has announced a major partnership with SK Biopharm, a South Korean pharmaceutical company, to advance artificial intelligence in drug discovery. The collaboration centers on Insilico's proprietary AI platform, which aims to accelerate the identification and development of novel drug candidates.
The agreement is structured with a